Previous work in pancreatic ductal adenocarcinoma has demonstrated that Sox15 is a potential tumor suppressor of the Wnt/β-catenin signaling pathway (Thu et al., 2014). This evidence concerns the gene SOX15 and pancreatic ductal adenocarcinoma.